Steve Gullans's guest appearances

Steve Gullans

Finding Genius Podcast

Impact Theory with Tom Bilyeu

Discover Popular Authors Audiobooks in Science & Technology, Biology

Mahmoud Ghannoum

Michael Breus

Emeran Mayer

Dale Bredesen

Aubrey de Grey

Naveen Jain

Steven Kotler

Jimmy Moore

Drew Manning

Kevin Kelly

Brian Keating

Elle Russ

Thomas Neumann

Alex Lu

Ilan Morad

OwlTail

Is natural selection as natural as it once was? Despite what we may think, natural selection, as laid out by Darwin, has little resemblance to mutations happening today. Listen up to learn:  What governs underlying change in our DNA Advances in the understanding of evolution and biology Why biotech can be a complex field to experiment in  This episode is sponsored by Bowmar Nutrition. To receive a 5% discount, use the code GENIUS5 at checkout. Go to BowmarNutrition.com to shop now! Steve Gullans, the author of Evolving Ourselves, shares his research in biotech and the world on how humans are changing the course of evolution. Darwinian concepts of natural selection have long been the gold standard for how we think of evolution. However, humans are significantly altering the course of evolution through means we could have never seen on the horizon in Darwin's time. Biotech holds countless new opportunities to take control of evolution and leave it in the hands of the individual. However, since biotech is a challenging field to research and test, we must be patient and wait for the great leap. Check out Evolving Ourselves to learn more! Episode also available on Apple Podcast: http://apple.co/30PvU9C  Episode is also available on Spotify: https://spoti.fi/36mLSwX

Is natural selection as natural as it once was? Despite what we may think, natural selection, as laid out by Darwin, has little resemblance to mutations happening today. Listen up to learn: <ul> <li>What governs underlying change in our DNA</li> <li>Advances in the understanding of evolution and biology</li> <li>Why biotech can be a complex field to experiment in</li> </ul> This episode is sponsored by Bowmar Nutrition. To receive a 5% discount, use the code GENIUS5 at checkout. Go to <a href="https://bowmarnutrition.com//" rel="nofollow" target="_blank">BowmarNutrition.com</a> to shop now! Steve Gullans, the author of Evolving Ourselves, shares his research in biotech and the world on how humans are changing the course of evolution. Darwinian concepts of natural selection have long been the gold standard for how we think of evolution. However, humans are significantly altering the course of evolution through means we could have never seen on the horizon in Darwin's time. Biotech holds countless new opportunities to take control of evolution and leave it in the hands of the individual. However, since biotech is a challenging field to research and test, we must be patient and wait for the great leap. Check out Evolving Ourselves to learn more! Episode also available on Apple Podcast: <a href="http://apple.co/30PvU9C" rel="noopener nofollow" target="_blank">http://apple.co/30PvU9C</a> Episode is also available on Spotify: <a href="https://spoti.fi/36mLSwX" rel="nofollow" target="_blank">https://spoti.fi/36mLSwX</a>

Evolving Ourselves - How Non-Random Mutations Are Changing Life On Earth As We Know It With Steve Gullans

There are natural alliances, when certain kinds of tumors end up in obvious places," says Steve Gullans, and because cancer cells know how to unlock entry into different types of cells and tissue, they naturally settle where their tools let them. This is how he answers Richard's question about communication and cancer cells. As coauthor of Richard's new cancer book, he shares years of insights and experience with listeners. Listen and learn  How, as part of the team to first sequence a tumor, he describes single-cell sequencing and informatics, Why immune cells like lymphocytes being present in tumors or around tumors makes a difference with effective drugs, How metastases are much harder to treat than primary tumors and what needs to be done to change that, and Why the microenvironment around tumors is an area currently under active investigation and what scientists hope to discover.  Steve Gullans has extensive experience in all aspects of the life sciences, from Chief Executive Officer of Gemphire Therapeutics to the co-founder and managing director of a life sciences venture capital firm. He's an academic scientist, speaker, and author and was been involved in cancer research and therapeutics for decades. He gives listeners a cogent take on what we know about tumor sequencing. For example, while a few genes show up repeatedly because they are fundamental to the mutation that is part of a tumor, "a single mutation is generally not sufficient" for a tumor to take hold. The immune system is too powerful. Instead, they have found sub mutations adapting to the environment. Furthermore, it’s the cells will to survive, to adapt to efforts like chemotherapy, which become the driver in cancer's progression. He gets specific about other types of drugs and therapies, addressing attempts to "untangle the web" of drugs being used, but also about the advances in what may be soon on its way. He says that there is a global effort to develop better treatment, and scientists are thinking about "these multiple cocktails of therapeutics and marrying the true diagnostic markers, the diagnostics with different regimens." Listen in for more about this promising research.  Episode also available on Apple Podcasts: apple.co/30PvU9C

There are natural alliances, when certain kinds of tumors end up in obvious places," says Steve Gullans, and because cancer cells know how to unlock entry into different types of cells and tissue, they naturally settle where their tools let them. This is how he answers Richard's question about communication and cancer cells. As coauthor of Richard's new cancer book, he shares years of insights and experience with listeners. Listen and learn <ul> <li>How, as part of the team to first sequence a tumor, he describes single-cell sequencing and informatics,</li> <li>Why immune cells like lymphocytes being present in tumors or around tumors makes a difference with effective drugs,</li> <li>How metastases are much harder to treat than primary tumors and what needs to be done to change that, and</li> <li>Why the microenvironment around tumors is an area currently under active investigation and what scientists hope to discover.</li> </ul> Steve Gullans has extensive experience in all aspects of the life sciences, from Chief Executive Officer of Gemphire Therapeutics to the co-founder and managing director of a life sciences venture capital firm. He's an academic scientist, speaker, and author and was been involved in cancer research and therapeutics for decades. He gives listeners a cogent take on what we know about tumor sequencing. For example, while a few genes show up repeatedly because they are fundamental to the mutation that is part of a tumor, "a single mutation is generally not sufficient" for a tumor to take hold. The immune system is too powerful. Instead, they have found sub mutations adapting to the environment. Furthermore, it’s the cells will to survive, to adapt to efforts like chemotherapy, which become the driver in cancer's progression. He gets specific about other types of drugs and therapies, addressing attempts to "untangle the web" of drugs being used, but also about the advances in what may be soon on its way. He says that there is a global effort to develop better treatment, and scientists are thinking about "these multiple cocktails of therapeutics and marrying the true diagnostic markers, the diagnostics with different regimens." Listen in for more about this promising research. Episode also available on Apple Podcasts: <a href="apple.co/30PvU9C" rel="nofollow" target="_blank">apple.co/30PvU9C</a>

Cancer Has the Keys: Steve Gullans Explains the Ecology of Tumors

Juan Enríquez

Tom Bilyeu reviews "Evolving Ourselves" by Juan Enríquez and Steve Gullans. This book is sure to shake up your ideas on natural selection and the future of humanity. Impact Books is a book review series that focuses on highlighting impactful books sure to free you from the Matrix. Every book reviewed will give you the insights and tools to help further you along your journey of transformation. Tom Bilyeu is the co-founder of 2014 Inc. 500 company Quest Nutrition — a unicorn startup valued at over $1 billion — and the co-founder and host of Impact Theory. Impact Theory is a first-of-its-kind company designed to facilitate global change through the incubation of mission-based businesses and the cultivation of empowering content. Every piece of content Impact Theory creates is meant to underscore the company mission to free people from The Matrix and help them unlock their true potential. Impact Theory exists to inspire the next generation of game-changing companies and creators that will make a true and lasting impact on the world. FOLLOW TOM BILYEU TWITTER: http://bit.ly/2iyjY5P INSTAGRAM: http://bit.ly/2j7vqX8 FACEBOOK: http://bit.ly/2hPStWo   FOLLOW IMPACT THEORY TWITTER: http://bit.ly/2iC5lN3 INSTAGRAM: http://bit.ly/2hPSGJa FACEBOOK: http://bit.ly/2iystOf Learn more about your ad choices. Visit megaphone.fm/adchoices

Tom Bilyeu reviews "Evolving Ourselves" by Juan Enríquez and Steve Gullans. This book is sure to shake up your ideas on natural selection and the future of humanity. Impact Books is a book review series that focuses on highlighting impactful books sure to free you from the Matrix. Every book reviewed will give you the insights and tools to help further you along your journey of transformation. Tom Bilyeu is the co-founder of 2014 Inc. 500 company Quest Nutrition — a unicorn startup valued at over $1 billion — and the co-founder and host of Impact Theory. Impact Theory is a first-of-its-kind company designed to facilitate global change through the incubation of mission-based businesses and the cultivation of empowering content. Every piece of content Impact Theory creates is meant to underscore the company mission to free people from The Matrix and help them unlock their true potential. Impact Theory exists to inspire the next generation of game-changing companies and creators that will make a true and lasting impact on the world. FOLLOW TOM BILYEU TWITTER: <a href="http://bit.ly/2iyjY5P" rel="nofollow" target="_blank">http://bit.ly/2iyjY5P</a> INSTAGRAM: <a href="http://bit.ly/2j7vqX8" rel="nofollow" target="_blank">http://bit.ly/2j7vqX8</a> FACEBOOK: <a href="http://bit.ly/2hPStWo" rel="nofollow" target="_blank">http://bit.ly/2hPStWo</a>   FOLLOW IMPACT THEORY TWITTER: <a href="http://bit.ly/2iC5lN3" rel="nofollow" target="_blank">http://bit.ly/2iC5lN3</a> INSTAGRAM: <a href="http://bit.ly/2hPSGJa" rel="nofollow" target="_blank">http://bit.ly/2hPSGJa</a> FACEBOOK: <a href="http://bit.ly/2iystOf" rel="nofollow" target="_blank">http://bit.ly/2iystOf</a> Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="nofollow" target="_blank">megaphone.fm/adchoices</a>

Impact Books: Evolving Ourselves by Juan Enríquez and Steve Gullans